These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7251906)

  • 1. Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.
    Krook A; Lindström B; Kjellander J; Järnerot G; Bodin L
    J Clin Pathol; 1981 Jun; 34(6):645-50. PubMed ID: 7251906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy.
    Hudson MJ; Hill MJ; Elliott PR; Berghouse LM; Burnham WR; Lennard-Jones JE
    J Med Microbiol; 1984 Dec; 18(3):335-45. PubMed ID: 6334160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of bacteroides species to metronidazole during treatment of patients with Crohn's disease and healthy individuals.
    Krook A; Kjellander J; Danielsson D
    Scand J Infect Dis; 1982; 14(1):45-8. PubMed ID: 7071526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of metronidazole and sulfasalazine on the fecal flora in patients with Crohn's disease.
    Danielsson D; Kjellander J; Järnerot G
    Scand J Gastroenterol; 1981; 16(2):183-92. PubMed ID: 6118940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effect of metronidazole and sulfasalazine on Crohn's disease in relation to changes in the fecal flora.
    Krook A; Järnerot G; Danielsson D
    Scand J Gastroenterol; 1981; 16(4):569-75. PubMed ID: 6119763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaerobic gram-negative faecal flora in patients with Crohn's disease and healthy subjects.
    Ruseler-van Embden JG; Both-Patoir HC
    Antonie Van Leeuwenhoek; 1983 Jun; 49(2):125-32. PubMed ID: 6614898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of metronidazole and its main metabolite in patients with active Crohn's disease: correlation with disease activity and therapeutic efficacy?
    Schneider MU; Riemann JF; Laudage G
    Chemotherapy; 1984; 30(6):345-52. PubMed ID: 6518833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the fecal flora of patients with Crohn's disease during treatment with metronidazole. A preliminary report.
    Krook A; Danielsson D; Kjellander J; Järnerot G
    Scand J Gastroenterol; 1979; 14(6):705-10. PubMed ID: 231297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile.
    Bolton RP; Culshaw MA
    Gut; 1986 Oct; 27(10):1169-72. PubMed ID: 3781329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of ampicillin, clindamycin, and metronidazole on faecal excretion of short-chain fatty acids in healthy subjects.
    Høverstad T; Carlstedt-Duke B; Lingaas E; Midtvedt T; Norin KE; Saxerholt H; Steinbakk M
    Scand J Gastroenterol; 1986 Jun; 21(5):621-6. PubMed ID: 3749800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Metronidazole in Crohn's disease.
    Cohen M
    Lancet; 1975 May; 1(7918):1236. PubMed ID: 48852
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metronidazole and sulfasalazine on the normal human faecal flora.
    Krook A
    Scand J Gastroenterol; 1981; 16(5):587-92. PubMed ID: 6119764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial.
    Levine A; Kori M; Kierkus J; Sigall Boneh R; Sladek M; Escher JC; Wine E; Yerushalmi B; Amil Dias J; Shaoul R; Veereman Wauters G; Boaz M; Abitbol G; Bousvaros A; Turner D
    Gut; 2019 Feb; 68(2):239-247. PubMed ID: 29420227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn's disease with a multidisciplinary platform.
    Midtvedt T; Zabarovsky E; Norin E; Bark J; Gizatullin R; Kashuba V; Ljungqvist O; Zabarovska V; Möllby R; Ernberg I
    PLoS One; 2013; 8(6):e66074. PubMed ID: 23840402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.
    Seksik P; Rigottier-Gois L; Gramet G; Sutren M; Pochart P; Marteau P; Jian R; Doré J
    Gut; 2003 Feb; 52(2):237-42. PubMed ID: 12524406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.
    Prantera C; Berto E; Scribano ML; Falasco G
    Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):602-6. PubMed ID: 10076781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study.
    De Cruz P; Kang S; Wagner J; Buckley M; Sim WH; Prideaux L; Lockett T; McSweeney C; Morrison M; Kirkwood CD; Kamm MA
    J Gastroenterol Hepatol; 2015 Feb; 30(2):268-78. PubMed ID: 25087692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection and the use of antibiotics in Crohn's disease.
    Keighley MR
    Can J Surg; 1984 Sep; 27(5):438-41. PubMed ID: 6383583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition.
    Shiga H; Kajiura T; Shinozaki J; Takagi S; Kinouchi Y; Takahashi S; Negoro K; Endo K; Kakuta Y; Suzuki M; Shimosegawa T
    Dig Liver Dis; 2012 Sep; 44(9):736-42. PubMed ID: 22622202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.